Innovation Capital

Innovation Capital SAS, established in 1996 and headquartered in Paris, is a venture capital firm that specializes in early-stage and growth financing. The firm targets the development and capitalization of small to medium-sized enterprises, primarily focusing on sectors such as telecommunications, information technology, biotechnology, life sciences, medical devices, clean technologies, and healthcare services. With a particular emphasis on companies based in the United States and Europe, especially France and Switzerland, Innovation Capital typically invests up to €6 million in initial financing for companies with revenues of up to €50 million. The firm may extend this investment to €10 million over multiple funding rounds. Additionally, Innovation Capital actively participates in the governance of its portfolio companies by having representatives on their boards of directors. The firm also maintains a presence in Silicon Valley, reflecting its commitment to innovative sectors.

Michel Desbard

Venture Partner, Information Technology

Valéry Huot

Managing Partner, Information Technology

Franck Noiret

General Partner, Information Technology

Chantal Parpex

President and Managing Partner, Healthcare

Frédéric Téboul

Chief Financial Officer and General Secretary

58 past transactions

GeoSpock

Series B in 2019
GeoSpock Limited is a spatial big data platform company based in Cambridge, United Kingdom, with additional offices in Tokyo and Singapore. Founded in 2013, it specializes in developing a data indexing platform that provides analytics, visualization, and insights across various scales of data. The company offers products such as GeoSpock DB Discovery and GeoSpock DB Enterprise, which are cloud-based services designed to manage and analyze location-tagged information. These tools facilitate dynamic data fusion and enable users to perform complex queries for performance analytics. GeoSpock's platform can be utilized in a range of applications, from real-time tracking of logistics fleets to optimizing operations in smart cities, helping to uncover hidden patterns and improve decision-making. By harnessing trillions of data points in seconds, GeoSpock aims to transform business operations and contribute to sustainability efforts, such as reducing traffic congestion.

Wandercraft

Series B in 2017
Wandercraft SAS, founded in 2012 and based in Paris, France, specializes in the development of exoskeleton technology aimed at patients with mobility limitations due to spinal cord injuries, neuromuscular diseases, and strokes. The company's flagship product, Atalante, is a self-balancing, hands-free exoskeleton designed for rehabilitation in health centers, allowing users to walk without the need for crutches or additional technical aids. CE-marked in 2019, Atalante is sold to European rehabilitation hospitals to enhance gait re-learning treatments. Additionally, Wandercraft is working on a more compact exoskeleton for personal mobility in everyday life. The company integrates expertise in areas such as robotics, artificial intelligence, and clinical applications, making it a pioneer in creating realistic, autonomous walking devices for individuals with walking impairments.

BioSerenity

Series A in 2017
BioSerenity souhaite aider la communauté scientifique à mieux comprendre l'épilepsie pour mieux la soigner. Une fois anonymisées et privées de tout lien avec le patient, les données recueillies seront mise à disposition des chercheurs de l'Institut du Cerveau et de la Moelle épinière (ICM). C'est un pas décisif pour faire avancer la recherche sur l'épilepsie et améliorer le futur du diagnostic

OpenHealth

Private Equity Round in 2017
OpenHealth is a provider of real-time processing of health consumption data.

Ekinops

Post in 2017
Ekinops is a provider of next-generation optical transport solutions for service providers and private networks. Its carrier-grade solutions leverage expertise in 10G transmission, aggregation and Forward Error Correction (FEC) to allow operators to cost-effectively increase data transport capacity over dark fiber, CWDM, DWDM, SONET/SDH, IP and SAN networks.

Paragon Id

Post in 2016
Paragon ID is a leader in identification solutions in the e-ID, transport, smart cities, traceability & brand protection sectors. Using the latest technologies such as RFID and NFC, Paragon ID provides smart cards, tickets, labels and tags to worldwide clients in diverse markets including public transport, manufacturing, logistics, gaming and retail. Paragon ID employs more than 600 staff, with manufacturing sites in three continents (US, Europe and Asia), close to its customers. Paragon ID is a part of Paragon Group, which is a leading provider of identification and customer communications services, and has a total turnover in excess of €650 million, and close to 5,000 employees. The Group combines generations of experience, with the latest innovations in technology and smart data, to enable responsive and meaningful interactions, between organisations and their customers.

Kayentis

Venture Round in 2016
Kayentis, SAS provides data and real-time information capture and collection solutions. It offers Digital Pen Paper (DPP) solutions for the clinical trial industry. The company also provides Clin'Form that allows data written using a DPP to be recorded in an information system and shared via a Web portal. It serves life sciences, finance, and manufacturing markets. The company was incorporated in 2004 and is headquartered in Gif sur Yvette, France.

H4D

Series B in 2016
Founded in 2008, H4D has remained true to its original mission: to overcome isolation from health care, whether geographic or social, while supporting preventative medicine initiatives, as well as the treatment and the monitoring of chronic diseases. They are committed to ensuring that health checks become a straightforward and accessible recourse to everyone. Their pledge to provide health care solutions for everyone, regardless of their geographic location or social environments, coheres with Their respect or medical and paramedical professionals. H4D’s health programs are always integrated into a global health plan and are supported by systematic communication with local healthcare stakeholders.

BIOMODEX

Seed Round in 2016
BIOMODEX is an innovative medical technology company based in Paris and Boston using 3D printing to create tissue-like anatomical twins from medical images, for patient-specific rehearsal and advanced training. The anatomically accurate twin is designed to provide critical tactile feedback to users which, when paired with our simulated blood flow stations, offers a unique and tailored end to end physician experience.

Expway

Venture Round in 2016
EXPWAY is the world leader in Mobile Broadcast and Multicast Solutions. The company's fastest growing market is on LTE BROADCAST i.e. eMBMS. Expway provides eMBMS BM-SC SERVERs that allow the operator to create multicast streams, both live TV and push files in any format, and broadcast them at the LTE network. Its eMBMS MIDDLEWARE controls the LTE modem, and receives and decodes the broadcast streams on the device.

Wandercraft

Series A in 2015
Wandercraft SAS, founded in 2012 and based in Paris, France, specializes in the development of exoskeleton technology aimed at patients with mobility limitations due to spinal cord injuries, neuromuscular diseases, and strokes. The company's flagship product, Atalante, is a self-balancing, hands-free exoskeleton designed for rehabilitation in health centers, allowing users to walk without the need for crutches or additional technical aids. CE-marked in 2019, Atalante is sold to European rehabilitation hospitals to enhance gait re-learning treatments. Additionally, Wandercraft is working on a more compact exoskeleton for personal mobility in everyday life. The company integrates expertise in areas such as robotics, artificial intelligence, and clinical applications, making it a pioneer in creating realistic, autonomous walking devices for individuals with walking impairments.

Crocus Technology

Series E in 2015
Crocus Technology International Corp. specializes in developing and supplying magnetic sensors and embedded memory solutions based on its patented magnetic logic unit technology. The company provides a range of magnetic sensor products, which include various architectures suitable for challenging environments, such as oil drilling, fluid level measurements, and solar energy applications. Its offerings cater to diverse sectors, including industrial, automotive, consumer electronics, and the Internet of Things. Additionally, Crocus Technology delivers magnetic random access memory products and technologies tailored for the semiconductor and electronic systems industries, addressing needs in telecommunications, networking, storage, computing, and handheld devices. Established in 2014, the company is headquartered in Santa Clara, California, with an additional office in Grenoble, France, and distributes its products through a network of sales distributors both domestically and internationally.

Zesty

Series A in 2015
Zesty Limited, a digital health company, provides on-demand access to healthcare appointments via desktop, tablet, mobile, and cross platform applications in Western Europe. It offers digital tools to healthcare providers for booking and managing appointments, reading letters digitally, and sharing copies of electronic medical records; and digital platform for patients to manage their health care right from their smartphone. It serves customers, including hospitals, community providers, and general practice surgeons. Zesty Limited was formerly known as Zesty Health Limited and changed its name to Zesty Limited in January 2014. The company was incorporated in 2012 and is based in London, United Kingdom.

FittingBox

Series B in 2014
FittingBox SAS is a company that specializes in virtual fitting solutions for eyewear, enhancing the customer experience for selecting glasses and sunglasses. Founded in 2006 and based in Labège, France, with an additional office in Florida, the company offers a range of web-based and in-store solutions. Its services include virtual mirrors for optical and e-commerce websites, as well as interactive kiosks and storefront windows. FittingBox aims to improve the fitting process for consumers while simultaneously providing tools to boost business for eyecare professionals. The company's inception was inspired by a personal need to see oneself in a mirror when purchasing glasses, leading to the innovation of a virtual mirror that transforms traditional fitting experiences.

Voluntis

Series D in 2014
Voluntis, Inc. develops digital therapeutic solutions for diabetes, oncology, and other therapeutic areas. It offers Insulia, a prescription-only medical device that provides type 2 diabetes patients with insulin dose recommendations and educational coaching messages based on blood glucose values and other diabetes-related data; and Diabeo, a digital solution for type 1 and type 2 patients treated on a basal-bolus insulin regimen, which suggests insulin dosage, through algorithmic calculations that are specific to the patient and based on their particular doses. Voluntis, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.

Maeglin Software

Venture Round in 2012
Maeglin Software is dedicated to freeing-up your mobile life by delivering state-of-the-art mobile Value Added Services to the Telecom industry.

Aldebaran Robotics

Series C in 2011
Aldebaran Robotics, founded in 2005 and based in Paris, France, specializes in the design, manufacture, and sale of autonomous humanoid robots primarily for entertainment and assistance purposes. The company's notable products include NAO, a 58-cm tall humanoid robot designed to be a friendly companion capable of movement, recognition, auditory engagement, and conversation. Another key product, Pepper, is a social robot that interacts with humans, recognizes their emotions, and operates autonomously. Additionally, Romeo, a larger humanoid robot at 140 cm, is developed for research focused on assisting the elderly and individuals with reduced autonomy, featuring functionalities such as opening doors, climbing stairs, and grasping objects. Aldebaran Robotics aims to advance the field of humanoid robotics through innovative solutions that enhance human-robot interaction and support various applications in care and therapy.

Cytheris

Series D in 2010
Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT).

IntegraGen

Venture Round in 2010
IntegraGen is a French biotech company based on the Genopole life science park in Evry, near Paris. It leverages its unique intellectual property, research expertise and privileged access to sample libraries to develop molecular markers for central nervous system and metabolic diseases. IntegraGen notably uses its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotech firms and other research providers.

OMNIlife science

Venture Round in 2010
OMNIlife science, Inc. was founded in 1999 as an organization committed to the design, manufacture and distribution of high quality orthopaedic devices. Their corporate headquarters are located in Massachusetts.

FittingBox

Venture Round in 2009
FittingBox SAS is a company that specializes in virtual fitting solutions for eyewear, enhancing the customer experience for selecting glasses and sunglasses. Founded in 2006 and based in Labège, France, with an additional office in Florida, the company offers a range of web-based and in-store solutions. Its services include virtual mirrors for optical and e-commerce websites, as well as interactive kiosks and storefront windows. FittingBox aims to improve the fitting process for consumers while simultaneously providing tools to boost business for eyecare professionals. The company's inception was inspired by a personal need to see oneself in a mirror when purchasing glasses, leading to the innovation of a virtual mirror that transforms traditional fitting experiences.

Santen

Series D in 2009
Santen is a pharmaceutical company specializing in the development and manufacture of ophthalmic products. With over 120 years of experience, it focuses primarily on prescription ophthalmic pharmaceuticals, which includes both prescription and over-the-counter medications. Santen also has a segment dedicated to medical devices. The company has a strong global presence, with clinical development networks across Europe, Japan, and the United States, and most of its revenue is generated from Japan and other Asian markets. Through dedicated research and collaboration, Santen aims to address unmet needs in ophthalmology, continuously innovating to enhance the quality of life for patients worldwide.

Radio Systemes Ingenierie

Series D in 2009
Radio Systemes Ingenierie S.A. provides wireless communication systems. It offers Visioguard, a wireless alarm system that provide remote video monitoring, local monitoring with a TV or a monitor, integrated Internet-server, and emails with attached video-files. The company was founded in 2000 and is based in Strasbourg, France.

Anevia

Series B in 2009
Anevia is a software company that specializes in providing IPTV and over-the-top (OTT) solutions for live television, streaming video, time-shifted TV, and video-on-demand services. Founded in 2003 and headquartered in Gentilly, France, Anevia has established itself as a leader in the multiscreen video services market, with over 1,000 deployments across 70 countries and millions of users accessing more than 25,000 live channels. The company's offerings include video compression technologies, multiscreen IPTV head-ends, cloud DVRs, and CDN solutions, enabling viewers to access high-quality content, including 4K UHD, on various devices. Anevia serves a diverse clientele, including telecom and pay-TV operators, TV broadcasters, and video service providers in sectors such as hospitality, healthcare, and corporate environments. The company also provides professional services, support, and training to enhance its clients' operational capabilities.

Stantum

Series B in 2009
Stantum, Inc. designs and manufactures multitouch surface controllers. Its products include Lemur, which is a control surface for audio and media applications; and DEXTER, a laptop sized control surface, which is used for controlling digital audio workstations. The company’s products are used by musicians, composers, discjockies, media artists, researchers, and developers. It offers its products through distributors and retailers internationally. The company was formerly known as JazzMutant SAS and changed its name in 2007. Stantum, Inc. was founded in 2002 and is based in Bordeaux, France with a liaison office in Tokyo, Japan.

Novaled

Series C in 2009
Novaled AG is a world-class technology provider in organic light-emitting diode (OLED) technologies. With expertise in synthetic and analytical chemistry, it offers complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials. Novaled has developed long-term partnerships with major OLED players worldwide. Its strong IP position in OLED technology is based on more than 500 patents granted or pending. In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia.

cacaoTV

Seed Round in 2008
Introduction to cacaoTV cacaoTV is a software that allows to view a streaming audio video media (i.e. TV channels) based on Peer to Peer (P2P) technology. cacaoTV works by using P2P technology, thus everyone when viewing media with cacaoweb client, the viewers upload content at the same time the programs are downloaded and viewed. cacaoweb creates a local stream on localhost and that stream is then read by Windows Media Player, Real Player or other media players. Since all viewers will upload content when viewing media, everyone becomes a broadcaster (server) without the cost of traditional streaming. And hence, the more users are online, the faster the programs can be loaded. And it will automatically find different connection nodes and download stream data from the nearest location (nodes). The good thing is, stream data is buffering in the memory, not on the hard disk. Channel Availability and Reliability Currently, most of the media contents are TV channels from the USA, and it includes some subscribers-based international channel such as HBO, ESPN, National Geographic and etc. Lately there are some independent channels that broadcast selective collection of media, such as latest blockbuster movies, collection of movies from a celebrity, or whole series of a drama. This kind of channels is created by individual viewers. There are also some radio channels available. Ease of Use and Speed of cacaoTV Just download cacaoweb and install it, and you’re ready to jump on the bandwagon of P2P TV. cacaoweb is able to work perfectly and stream smoothly without any configuration.

Crocus Technology

Series B in 2008
Crocus Technology International Corp. specializes in developing and supplying magnetic sensors and embedded memory solutions based on its patented magnetic logic unit technology. The company provides a range of magnetic sensor products, which include various architectures suitable for challenging environments, such as oil drilling, fluid level measurements, and solar energy applications. Its offerings cater to diverse sectors, including industrial, automotive, consumer electronics, and the Internet of Things. Additionally, Crocus Technology delivers magnetic random access memory products and technologies tailored for the semiconductor and electronic systems industries, addressing needs in telecommunications, networking, storage, computing, and handheld devices. Established in 2014, the company is headquartered in Santa Clara, California, with an additional office in Grenoble, France, and distributes its products through a network of sales distributors both domestically and internationally.

TxCell

Series B in 2008
TxCell S.A. is a biotechnology company based in Valbonne, France, specializing in cellular immunotherapies that leverage regulatory T cells (Tregs) to address severe chronic inflammatory diseases, autoimmunity, and transplantation challenges. The company develops innovative therapies using Tregs engineered with chimeric antigen receptors (CARs) for various conditions, including TX200, aimed at preventing graft rejection in solid organ transplants, and treatments for autoimmune diseases such as bullous pemphigoid and multiple sclerosis. TxCell is also advancing Ovasave, a therapy for refractory Crohn's disease, having completed an initial study with positive outcomes and planning further clinical trials. The company collaborates with prominent research institutions, including the Lübeck Institute of Experimental Dermatology and the University of British Columbia, to enhance its research and development efforts. TxCell operates as a subsidiary of Sangamo Therapeutics, Inc., continuing its focus on innovative immunotherapy solutions.

EI-Technologies

Venture Round in 2008
EI-Technologies is a Paris-based company that specializes in IT consulting and internet software development services. Founded in 1994, the firm provides a range of solutions, including Salesforce implementations, workplace solutions branded as EI-Workplace, and training programs on Salesforce technologies through its EI-Institut. With a focus on maintaining a skilled and expert workforce, EI-Technologies emphasizes quality management and a collaborative work environment. As of May 2020, it operates as a subsidiary of Cognizant Technology Solutions Corporation.

Santaris Pharma

Series C in 2007
Santaris Pharma A/S is a privately held clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discovery Engine developed by Santaris Pharma A/S combine the company’s proprietary LNA chemistry with its highly specialized and targeted drug development capabilities to rapidly deliver potent single-stranded LNA-based drug candidates across a multitude of disease states. The company’s research and development activities focus on infectious diseases and cardiometabolic disorders, while partnerships with major pharmaceutical companies include a range of therapeutic areas including cancer, cardiovascular disease, infectious and inflammatory diseases, and rare genetic disorders. The company has strategic partnerships with miRagen Therapeutics, Shire PLC, Pfizer, GlaxoSmithKline, and Enzon Pharmaceuticals. As part of its broad patent estate, the company holds exclusive worldwide rights to manufacture, have manufactured and sell products that contain LNA as an active ingredient for studies performed with a view to obtaining marketing approval. Santaris Pharma A/S, founded in 2003, is headquartered in Denmark with operations in the United States.

Wirecom Technologies

Series B in 2007
WIRECOM Technologies is a French company with state-of-the-art technology and an experience of over 10 years. Committed to sustainable development and the fight against global warming, WIRECOM Technologies designs and develops solutions to optimise energy efficiency in buildings and residences

Iwedia

Series D in 2007
Iwedia Technologies S.A., through its divisions, provides software solutions for connected audiovisual digital terminals; and engineering services in the whole digital image chain. It also offers software components and customized solutions. The company was founded in 2004 and is headquartered in Rennes, France.

Aldebaran Robotics

Series A in 2007
Aldebaran Robotics, founded in 2005 and based in Paris, France, specializes in the design, manufacture, and sale of autonomous humanoid robots primarily for entertainment and assistance purposes. The company's notable products include NAO, a 58-cm tall humanoid robot designed to be a friendly companion capable of movement, recognition, auditory engagement, and conversation. Another key product, Pepper, is a social robot that interacts with humans, recognizes their emotions, and operates autonomously. Additionally, Romeo, a larger humanoid robot at 140 cm, is developed for research focused on assisting the elderly and individuals with reduced autonomy, featuring functionalities such as opening doors, climbing stairs, and grasping objects. Aldebaran Robotics aims to advance the field of humanoid robotics through innovative solutions that enhance human-robot interaction and support various applications in care and therapy.

Citilog

Series D in 2006
Citilog S.A. specializes in video-based real-time monitoring and surveillance solutions tailored for the transportation sector. The company develops Automatic Incident Detection systems that swiftly identify incidents on highways, bridges, and tunnels, as well as traffic data collection tools that support statistics, planning, and real-time information for road users. Its product lineup includes MediaCity, which detects traffic presence and provides data such as speed and vehicle counts, and MediaManager, a comprehensive traffic and incident management software platform. Citilog also offers various sensors, including those for license plate recognition and detection of vehicles carrying hazardous materials. These products are integral to enhancing road safety and mobility in smart cities. Established in 1997 and headquartered in Arcueil, France, Citilog operates additional offices in the United States, Spain, and Hong Kong, distributing its solutions through value-added resellers and distributors worldwide.

Crocus Technology

Series A in 2006
Crocus Technology International Corp. specializes in developing and supplying magnetic sensors and embedded memory solutions based on its patented magnetic logic unit technology. The company provides a range of magnetic sensor products, which include various architectures suitable for challenging environments, such as oil drilling, fluid level measurements, and solar energy applications. Its offerings cater to diverse sectors, including industrial, automotive, consumer electronics, and the Internet of Things. Additionally, Crocus Technology delivers magnetic random access memory products and technologies tailored for the semiconductor and electronic systems industries, addressing needs in telecommunications, networking, storage, computing, and handheld devices. Established in 2014, the company is headquartered in Santa Clara, California, with an additional office in Grenoble, France, and distributes its products through a network of sales distributors both domestically and internationally.

NEMOPTIC

Series D in 2006
Nemoptic, an epaper display company, designs and manufactures superior-quality bistable liquid crystal displays (LCD) modules highly suitable for consumer and professional mobile devices.

Santen

Post in 2006
Santen is a pharmaceutical company specializing in the development and manufacture of ophthalmic products. With over 120 years of experience, it focuses primarily on prescription ophthalmic pharmaceuticals, which includes both prescription and over-the-counter medications. Santen also has a segment dedicated to medical devices. The company has a strong global presence, with clinical development networks across Europe, Japan, and the United States, and most of its revenue is generated from Japan and other Asian markets. Through dedicated research and collaboration, Santen aims to address unmet needs in ophthalmology, continuously innovating to enhance the quality of life for patients worldwide.

Iwedia

Series C in 2006
Iwedia Technologies S.A., through its divisions, provides software solutions for connected audiovisual digital terminals; and engineering services in the whole digital image chain. It also offers software components and customized solutions. The company was founded in 2004 and is headquartered in Rennes, France.

Wirecom Technologies

Series A in 2006
WIRECOM Technologies is a French company with state-of-the-art technology and an experience of over 10 years. Committed to sustainable development and the fight against global warming, WIRECOM Technologies designs and develops solutions to optimise energy efficiency in buildings and residences

Novaled

Series B in 2005
Novaled AG is a world-class technology provider in organic light-emitting diode (OLED) technologies. With expertise in synthetic and analytical chemistry, it offers complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials. Novaled has developed long-term partnerships with major OLED players worldwide. Its strong IP position in OLED technology is based on more than 500 patents granted or pending. In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia.

Graitec

Series C in 2005
GRAITEC Innovation SAS is a BIM software company that develops advanced computer-aided design and analysis solutions for the construction engineering sector. Founded in 1986 and based in Bièvres, France, GRAITEC offers a range of products, including Advance Design for finite element method structural analysis, Advance BIM Designers for structural design and documentation, and various Autodesk software tools like AutoCAD and Revit. The company's solutions streamline the structural design and construction documentation process, enhancing efficiency through features such as automatic document creation and project tracking. GRAITEC also provides supplementary tools like PowerPack add-ons for Revit and Advance Steel, as well as BIM Connect for intelligent model sharing. In addition to software, GRAITEC offers technical support, professional training, custom software development, and project mentoring services. Operating through 29 offices across 12 countries, GRAITEC serves over 40,000 construction professionals worldwide, focusing on innovation and productivity in the architecture, engineering, and construction industry.

Iwedia

Series B in 2005
Iwedia Technologies S.A., through its divisions, provides software solutions for connected audiovisual digital terminals; and engineering services in the whole digital image chain. It also offers software components and customized solutions. The company was founded in 2004 and is headquartered in Rennes, France.

Ipracom

Series B in 2005
Ipracom SA develops software solutions focusing on PDA's and smart-phones. The company offers products such as Ipra*Cool and Ipra*PC that enable users to connect to PC's for accessing files or check e-mail. It also develops software for vertical applications. The company's clientele includes Orange, Bouygues Telecom, and Smart Communications. Ipracom is based in Massy, France. As of November 12, 2007, Ipracom SA is a subsidiary of Maeglin Software.

Zealand Pharma

Venture Round in 2005
Zealand Pharma A/S, a biotechnology company, engages in the discovery and development of peptide-based medicines in Denmark. It has a portfolio of medicines in development stage focusing on gastrointestinal and metabolic diseases. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes glepaglutide, a long acting GLP-2 analog, which is in Phase 3 clinical trials for the treatment of short bowel syndrome; and dasiglucagon, a stable glucagon analog for the treatment of severe hypoglycemia in diabetes and congenital hyperinsulinism, as well as for use in dual-hormone artificial pancreas for automated diabetes management. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; and Beta Bionics, Inc. to initiate home-use trial of the iLet bionic pancreas with dasiglucagon for autonomous bihormonal treatment of type 1 diabetes, as well as research agreement with Orbit Discovery Ltd. and Torrey Pines Institute for Molecular Studies. The company was founded in 1997 and is headquartered in Copenhagen, Denmark.

Kuros Biosciences

Post in 2005
Kuros Biosciences AG, a biopharmaceutical company, engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases in the United States, the United Kingdom, and internationally. Its sealants pipeline products include Neuroseal EU and US for the treatment of dural sealant cranial. The company’s orthobiologics pipeline products comprise MagnetOs Granules and MagnetOs Putty in EU and US for the treatment of orthopedics, spinal, and dental problems. Its fibrin/PTH orthobiologics pipeline products include KUR-111, which has completed Phase II clinical trial for the treatment of tibial plateau fractures; KUR-113, which completed Phase II clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase I trial for the treatment of spinal interbody fusion. The company has collaborations with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. Kuros Biosciences AG is based in Schlieren, Switzerland.

Radio Systemes Ingenierie

Series C in 2004
Radio Systemes Ingenierie S.A. provides wireless communication systems. It offers Visioguard, a wireless alarm system that provide remote video monitoring, local monitoring with a TV or a monitor, integrated Internet-server, and emails with attached video-files. The company was founded in 2000 and is based in Strasbourg, France.

Santen

Series B in 2004
Santen is a pharmaceutical company specializing in the development and manufacture of ophthalmic products. With over 120 years of experience, it focuses primarily on prescription ophthalmic pharmaceuticals, which includes both prescription and over-the-counter medications. Santen also has a segment dedicated to medical devices. The company has a strong global presence, with clinical development networks across Europe, Japan, and the United States, and most of its revenue is generated from Japan and other Asian markets. Through dedicated research and collaboration, Santen aims to address unmet needs in ophthalmology, continuously innovating to enhance the quality of life for patients worldwide.

RocTool

Venture Round in 2004
RocTool S.A. provides induction heating systems, tooling hardware products, power units, and peripherals in France and internationally. It offers generators, interfaces, and cooling units; and installation, design, and engineering services. The company serves automotive, consumer electronics, consumer goods, aerospace, and medical markets. RocTool S.A. is headquartered in Le Bourget du Lac, France.

Santen

Post in 2003
Santen is a pharmaceutical company specializing in the development and manufacture of ophthalmic products. With over 120 years of experience, it focuses primarily on prescription ophthalmic pharmaceuticals, which includes both prescription and over-the-counter medications. Santen also has a segment dedicated to medical devices. The company has a strong global presence, with clinical development networks across Europe, Japan, and the United States, and most of its revenue is generated from Japan and other Asian markets. Through dedicated research and collaboration, Santen aims to address unmet needs in ophthalmology, continuously innovating to enhance the quality of life for patients worldwide.

Theradiag

Series B in 2003
Theradiag SA is a France-based company that specializes in the development, manufacturing, and marketing of in-vitro diagnostic products. Established in 1986 and located in Marne La Vallée, the company offers a range of solutions including autoimmunity reagents, quality control tools, and instruments for testing autoimmune and infectious diseases. Notable products include the SQA-V semen analyzer and the V-Sperm system for sample documentation. Theradiag also provides advanced instrumentation such as the Theralis platform, which integrates multiple diagnostic techniques, and the Theralis µ, designed for medium-sized laboratories. Additionally, the company offers therapeutic drug monitoring services for chronic inflammatory diseases and the LISA tracker, a tool for monitoring biotherapies.

Kaidara

Series B in 2003
Kaidara is a software company that specializes in delivering advanced service and support solutions aimed at enhancing customer service for manufacturers of complex products. By facilitating the transfer of expert knowledge within organizations, Kaidara's software streamlines product selection, support, and repair activities, ultimately reducing service delivery costs and accelerating problem resolution. Its tools are particularly beneficial for customer contact centers, field service organizations, and diagnostic troubleshooting operations. The software also supports online commerce and self-service portals by assisting customers in product selection and troubleshooting, while providing expert advice on product usage. Additionally, Kaidara's natural language processing capabilities help organizations capture and preserve valuable knowledge and experiences, ensuring that expert guidance remains accessible. Based in Paris and Los Altos, Kaidara serves a diverse clientele, including major companies like CFM International, DaimlerChrysler, and General Motors, all of which benefit from improved customer service and reduced operational costs.

Teem Photonics

Venture Round in 2003
Teem Photonics S.A. is a manufacturer specializing in passively Q-switched micro lasers and ion-exchange integrated optics for various industrial applications. The company offers a range of laser technologies, including infrared, green, and ultraviolet lasers, along with products for three-dimensional microfabrication. These technologies are utilized in sectors such as biomedical, marking, sensing, scanning, material processing, and electronic applications. Additionally, Teem Photonics develops custom integrated optics devices and solutions for silicon photonics connections. The company provides a comprehensive suite of services, including optical design, foundry services, testing, assembly, and packaging. Founded in 1998 and headquartered in Meylan, France, Teem Photonics has expanded its presence with offices across Europe, Asia, the Pacific, North America, and Mexico.

Kuros Biosciences

Series A in 2002
Kuros Biosciences AG, a biopharmaceutical company, engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases in the United States, the United Kingdom, and internationally. Its sealants pipeline products include Neuroseal EU and US for the treatment of dural sealant cranial. The company’s orthobiologics pipeline products comprise MagnetOs Granules and MagnetOs Putty in EU and US for the treatment of orthopedics, spinal, and dental problems. Its fibrin/PTH orthobiologics pipeline products include KUR-111, which has completed Phase II clinical trial for the treatment of tibial plateau fractures; KUR-113, which completed Phase II clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase I trial for the treatment of spinal interbody fusion. The company has collaborations with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. Kuros Biosciences AG is based in Schlieren, Switzerland.

Drug Abuse Sciences

Series A in 2001
Drug Abuse Sciences develops and commercializes therapies for the treatment of alcohol and drug addictions. It offers Naltrexone Depot, a sustained-release formulation of Naltrexone for the treatment of alcohol and opiate addictions; DAS-431 for the treatment of cocaine addiction; and Buprenorphine Depot, a sustained-release formulation of buprenorphine for the treatment of heroin and various opiate addictions. Drug Abuse Sciences is based in Menlo Park, California.

Theradiag

Series A in 2000
Theradiag SA is a France-based company that specializes in the development, manufacturing, and marketing of in-vitro diagnostic products. Established in 1986 and located in Marne La Vallée, the company offers a range of solutions including autoimmunity reagents, quality control tools, and instruments for testing autoimmune and infectious diseases. Notable products include the SQA-V semen analyzer and the V-Sperm system for sample documentation. Theradiag also provides advanced instrumentation such as the Theralis platform, which integrates multiple diagnostic techniques, and the Theralis µ, designed for medium-sized laboratories. Additionally, the company offers therapeutic drug monitoring services for chronic inflammatory diseases and the LISA tracker, a tool for monitoring biotherapies.

Santen

Post in 2000
Santen is a pharmaceutical company specializing in the development and manufacture of ophthalmic products. With over 120 years of experience, it focuses primarily on prescription ophthalmic pharmaceuticals, which includes both prescription and over-the-counter medications. Santen also has a segment dedicated to medical devices. The company has a strong global presence, with clinical development networks across Europe, Japan, and the United States, and most of its revenue is generated from Japan and other Asian markets. Through dedicated research and collaboration, Santen aims to address unmet needs in ophthalmology, continuously innovating to enhance the quality of life for patients worldwide.

6WIND

Seed Round in 2000
6WIND S.A. specializes in the design and development of networking software tailored for developers, large enterprises, and the networking and telecom sectors. Founded in 2000 and headquartered in Montigny-le-Bretonneux, France, with additional offices in the United States, China, Japan, and South Korea, the company offers a range of solutions including network function virtualization, software-defined networking, and network security. Key products include 6WINDGate, which enhances data plane processing throughput significantly compared to standard Linux networking stacks, and 6WIND Virtual Accelerator, designed for virtualized infrastructures. 6WIND’s offerings also feature Turbo Router software for both bare metal and virtual environments, as well as secure site-to-site VPN solutions. The company’s innovative software architecture enables optimal performance in both physical and virtual settings, allowing for substantial cost reductions in capital and operational expenditures while maximizing networking capabilities on standard hardware platforms.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.